BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28892096)

  • 1. Development and characterization of cholangioids from normal and diseased human cholangiocytes as an in vitro model to study primary sclerosing cholangitis.
    Loarca L; De Assuncao TM; Jalan-Sakrikar N; Bronk S; Krishnan A; Huang B; Morton L; Trussoni C; Bonilla LM; Krueger E; O'Hara S; Splinter P; Shi G; Pisarello MJL; Gores GJ; Huebert RC; LaRusso NF
    Lab Invest; 2017 Nov; 97(11):1385-1396. PubMed ID: 28892096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced Pluripotent Stem Cells From Subjects With Primary Sclerosing Cholangitis Develop a Senescence Phenotype Following Biliary Differentiation.
    Jalan-Sakrikar N; De Assuncao TM; Navarro-Corcuera A; Hamdan FH; Loarca L; Kirkeby LA; Resch ZT; O'Hara SP; Juran BD; Lazaridis KN; Rosen CB; Heimbach JK; Taner T; Shah VH; LaRusso NF; Huebert RC
    Hepatol Commun; 2022 Feb; 6(2):345-360. PubMed ID: 34519176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human placenta mesenchymal stem cell-derived exosomes delay H
    Chen W; Zhu J; Lin F; Xu Y; Feng B; Feng X; Sheng X; Shi X; Pan Q; Yang J; Yu J; Li L; Cao H
    Stem Cell Res Ther; 2021 Mar; 12(1):201. PubMed ID: 33752720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholangiocyte senescence by way of N-ras activation is a characteristic of primary sclerosing cholangitis.
    Tabibian JH; O'Hara SP; Splinter PL; Trussoni CE; LaRusso NF
    Hepatology; 2014 Jun; 59(6):2263-75. PubMed ID: 24390753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic or pharmacological reduction of cholangiocyte senescence improves inflammation and fibrosis in the
    Alsuraih M; O'Hara SP; Woodrum JE; Pirius NE; LaRusso NF
    JHEP Rep; 2021 Jun; 3(3):100250. PubMed ID: 33870156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Senescent cholangiocytes release extracellular vesicles that alter target cell phenotype via the epidermal growth factor receptor.
    Al Suraih MS; Trussoni CE; Splinter PL; LaRusso NF; O'Hara SP
    Liver Int; 2020 Oct; 40(10):2455-2468. PubMed ID: 32558183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of cultured cholangiocytes isolated from livers of patients with primary sclerosing cholangitis.
    Tabibian JH; Trussoni CE; O'Hara SP; Splinter PL; Heimbach JK; LaRusso NF
    Lab Invest; 2014 Oct; 94(10):1126-33. PubMed ID: 25046437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.
    Chung BK; Karlsen TH; Folseraas T
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1390-1400. PubMed ID: 28844951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Epigenetic Reader, Bromodomain Containing 2, Mediates Cholangiocyte Senescence via Interaction With ETS Proto-Oncogene 1.
    Kang JH; Splinter PL; Trussoni CE; Pirius NE; Gores GJ; LaRusso NF; O'Hara SP
    Gastroenterology; 2023 Jul; 165(1):228-243.e2. PubMed ID: 37059338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholangiocyte senescence in primary sclerosing cholangitis is associated with disease severity and prognosis.
    Cazzagon N; Sarcognato S; Floreani A; Corrà G; De Martin S; Guzzardo V; Russo FP; Guido M
    JHEP Rep; 2021 Jun; 3(3):100286. PubMed ID: 34041468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockout of secretin receptor reduces biliary damage and liver fibrosis in Mdr2
    Zhou T; Wu N; Meng F; Venter J; Giang TK; Francis H; Kyritsi K; Wu C; Franchitto A; Alvaro D; Marzioni M; Onori P; Mancinelli R; Gaudio E; Glaser S; Alpini G
    Lab Invest; 2018 Nov; 98(11):1449-1464. PubMed ID: 29977037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ETS Proto-oncogene 1 Transcriptionally Up-regulates the Cholangiocyte Senescence-associated Protein Cyclin-dependent Kinase Inhibitor 2A.
    O'Hara SP; Splinter PL; Trussoni CE; Pisarello MJ; Loarca L; Splinter NS; Schutte BF; LaRusso NF
    J Biol Chem; 2017 Mar; 292(12):4833-4846. PubMed ID: 28184004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular senescence in the cholangiopathies: a driver of immunopathology and a novel therapeutic target.
    Trussoni CE; O'Hara SP; LaRusso NF
    Semin Immunopathol; 2022 Jul; 44(4):527-544. PubMed ID: 35178659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Scaffold-Free Three-Dimensional Cholangiocyte Organoids to Study the Progression of Primary Sclerosing Cholangitis.
    Zhang W; Kyritsi K; Isidan A; Park Y; Li P; Cross-Najafi AA; Lopez K; Kennedy L; Sato K; Glaser S; Francis H; Alpini G; Ekser B
    Am J Pathol; 2023 Sep; 193(9):1156-1169. PubMed ID: 37263345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological features of primary sclerosing cholangitis identified by bile proteomic analysis.
    Rupp C; Bode KA; Leopold Y; Sauer P; Gotthardt DN
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1380-1389. PubMed ID: 28943450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomere dysfunction promotes cholangiocyte senescence and biliary fibrosis in primary sclerosing cholangitis.
    Jalan-Sakrikar N; Anwar A; Yaqoob U; Gan C; Lagnado AB; Wixom AQ; Jurk D; Huebert RC
    JCI Insight; 2023 Oct; 8(20):. PubMed ID: 37707950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of p16 Decreases Biliary Damage and Liver Fibrosis in the Mdr2
    Kyritsi K; Francis H; Zhou T; Ceci L; Wu N; Yang Z; Meng F; Chen L; Baiocchi L; Kundu D; Kennedy L; Liangpunsakul S; Wu C; Glaser S; Alpini G
    Gene Expr; 2020 Nov; 20(2):89-103. PubMed ID: 32393417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice.
    Guicciardi ME; Trussoni CE; Krishnan A; Bronk SF; Lorenzo Pisarello MJ; O'Hara SP; Splinter PL; Gao Y; Vig P; Revzin A; LaRusso NF; Gores GJ
    J Hepatol; 2018 Sep; 69(3):676-686. PubMed ID: 29802947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the secretin/secretin receptor axis in inflammatory cholangiocyte communication via extracellular vesicles.
    Sato K; Meng F; Venter J; Giang T; Glaser S; Alpini G
    Sci Rep; 2017 Sep; 7(1):11183. PubMed ID: 28894209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of cholangiocyte responses to injury.
    Sato K; Meng F; Giang T; Glaser S; Alpini G
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1262-1269. PubMed ID: 28648950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.